Ryon Graf

Ryon Graf

Foundation Medicine Inc. - Cambridge / United States
Others
AD Scientific Index ID: 4465140
-
person_outline Ryon Graf's MOST POPULAR ARTICLES
1-) Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancerHI Scher, D Lu, NA Schreiber, J Louw, RP Graf, HA Vargas, A Johnson, ...JAMA oncology 2 (11), 1441-1449, 20165782016
2-) Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancerHI Scher, RP Graf, NA Schreiber, A Jayaram, E Winquist, B McLaughlin, ...JAMA oncology 4 (9), 1179-1186, 20181842018
3-) Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a …KA Autio, R Dreicer, J Anderson, JA Garcia, A Alva, LL Hart, MI Milowsky, ...JAMA oncology 4 (10), 1344-1351, 20181602018
4-) Nuclear-specific AR-V7 protein localization is necessary to guide treatment selection in metastatic castration-resistant prostate cancerHI Scher, RP Graf, NA Schreiber, B McLaughlin, D Lu, J Louw, DC Danila, ...European urology 71 (6), 874-882, 20171832017
5-) Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancerK Boudadi, DL Suzman, V Anagnostou, W Fu, B Luber, H Wang, ...Oncotarget 9 (47), 28561, 20181542018